T1	Person 0 3	Men
T2	Person 20 25	women
T3	Qualifier 7 19	non-pregnant
R1	Has_qualifier Arg1:T2 Arg2:T3	
T4	Person 63 66	age
T5	Value 70 89	18 and 45 years old
R2	Has_value Arg1:T4 Arg2:T5	
T6	Person 108 119	non-smokers
*	OR T2 T1
T7	Informed_consent 369 443	Provide written informed consent before initiation of any study procedures
T8	Post-eligibility 445 506	Available for follow-up for the planned duration of the study
T9	Non-query-able 508 555	Able to communicate well with the investigators
T10	Post-eligibility 557 647	Able to adhere to the study protocol schedule, study restrictions and examination schedule
T11	Measurement 698 701	BMI
T12	Value 702 727	between >17 and =28 kg/m2
R3	Has_value Arg1:T11 Arg2:T12	
T13	Non-query-able 730 895	Subjects deemed to be healthy as judged by the Medically Accountable Investigator (MAI) and determined by medical history, physical examination and medication histor
T14	Condition 971 975	pain
T15	Qualifier 949 954	acute
T16	Qualifier 958 970	intermittent
T17	Scope 949 970	acute or intermittent
R4	Has_scope Arg1:T14 Arg2:T17	
T18	Condition 991 995	pain
T19	Qualifier 977 990	postoperative
R5	Has_qualifier Arg1:T18 Arg2:T19	
T20	Condition 997 1019	respiratory compromise
T21	Condition 1037 1043	asthma
T22	Qualifier 1021 1026	acute
T23	Qualifier 1030 1036	severe
T24	Negation 912 914	no
*	OR T23 T22
T25	Scope 1021 1036	acute or severe
R6	Has_scope Arg1:T21 Arg2:T25	
T26	Condition 1048 1060	constipation
T27	Scope 949 1060	acute or intermittent pain, postoperative pain, respiratory compromise, acute or severe asthma, or constipation
R7	Has_negation Arg1:T27 Arg2:T24	
T28	Measurement 1113 1138	urine drug screening test
T29	Value 1104 1112	Negative
R8	Has_value Arg1:T28 Arg2:T29	
T30	Value 1170 1176	normal
T31	Measurement 1204 1221	white blood cells
T32	Measurement 1223 1226	WBC
T33	Measurement 1229 1239	hemoglobin
T34	Measurement 1241 1244	Hgb
T35	Measurement 1247 1256	platelets
T36	Measurement 1258 1264	sodium
T37	Measurement 1266 1275	potassium
T38	Measurement 1277 1285	chloride
T39	Measurement 1287 1298	bicarbonate
T40	Measurement 1300 1319	blood urea nitrogen
T41	Measurement 1321 1324	BUN
T42	Measurement 1327 1337	creatinine
T43	Measurement 1339 1342	ALT
T44	Measurement 1361 1364	AST
T45	Measurement 1386 1395	bilirubin
R9	Subsumes Arg1:T31 Arg2:T32	
R10	Subsumes Arg1:T33 Arg2:T34	
R11	Subsumes Arg1:T40 Arg2:T41	
T46	Scope 1204 1395	white blood cells (WBC), hemoglobin (Hgb), platelets, sodium, potassium, chloride, bicarbonate, blood urea nitrogen (BUN), creatinine, ALT (liver function), AST (liver function) and bilirubin
R12	Has_value Arg1:T46 Arg2:T30	
T47	Value 1402 1408	normal
T48	Measurement 1436 1449	urine protein
T49	Measurement 1454 1467	urine glucose
T50	Scope 1436 1467	urine protein and urine glucose
R13	Has_value Arg1:T50 Arg2:T47	
*	OR T16 T15
T51	Pregnancy_considerations 1469 2016	Female subjects must be of non-childbearing potential (as defined as surgically sterile [i.e. history of hysterectomy or tubal ligation] or postmenopausal for more than 1 year [no bleeding for 12 consecutive months], or if of childbearing potential must be non-pregnant at the time of enrollment and on the morning of the first day of each study session, and must agree to use hormonal or barrier birth control such as implants, injectables, combined oral contraceptives, some intrauterine devices (IUDs), sexual abstinence or a vasectomized parte
T52	Competing_trial 2019 2199	Agrees not to participate in another clinical study/trial during the study period or to participate in an investigational drug study for at least one month after last study session
T53	Non-query-able 2202 2328	grees not to donate blood to a blood bank throughout participation in the study and for at least 3 months after last study day
T54	Measurement 2344 2347	ECG
T55	Value 2337 2343	normal
R14	Has_value Arg1:T54 Arg2:T55	
T56	Negation 2354 2357	not
T57	Observation 2395 2426	pathologic Q wave abnormalities
T58	Observation 2440 2457	ST-T wave changes
T59	Condition 2459 2487	left ventricular hypertrophy
T60	Condition 2489 2514	right bundle branch block
T61	Condition 2516 2540	left bundle branch block
T62	Scope 2395 2541	pathologic Q wave abnormalities, significant ST-T wave changes, left ventricular hypertrophy, right bundle branch block, left bundle branch block.
R15	Has_negation Arg1:T62 Arg2:T56	
T63	Measurement 2593 2604	Temperature
T64	Value 2605 2614	35-37.9°C
T65	Value 2616 2626	95-100.3°F
R16	Subsumes Arg1:T64 Arg2:T65	
R17	Has_value Arg1:T63 Arg2:T64	
T66	Measurement 2629 2652	Systolic blood pressure
T67	Value 2653 2664	90-140 mmHg
R18	Has_value Arg1:T66 Arg2:T67	
T68	Measurement 2666 2690	Diastolic blood pressure
T69	Value 2691 2701	60-90 mmHg
R19	Has_value Arg1:T68 Arg2:T69	
T70	Measurement 2703 2713	Heart rate
T71	Value 2714 2737	55-100 beats per minute
R20	Has_value Arg1:T70 Arg2:T71	
T72	Measurement 2739 2755	Respiration rate
T73	Value 2756 2780	12-18 breaths per minute
R21	Has_value Arg1:T72 Arg2:T73	
